Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| epithelial cell of proximal tubule | 6 studies | 29% ± 7% | |
| epithelial cell | 6 studies | 34% ± 9% | |
| ciliated cell | 3 studies | 24% ± 6% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| liver | 3 studies | 18% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 331.69 | 1439 / 1445 | 100% | 39.68 | 183 / 183 |
| ovary | 99% | 253.60 | 179 / 180 | 100% | 39.71 | 430 / 430 |
| liver | 100% | 1256.62 | 226 / 226 | 99% | 35.33 | 403 / 406 |
| kidney | 100% | 1513.94 | 89 / 89 | 99% | 50.37 | 893 / 901 |
| intestine | 100% | 462.47 | 966 / 966 | 99% | 39.36 | 522 / 527 |
| bladder | 100% | 374.05 | 21 / 21 | 98% | 25.72 | 493 / 504 |
| stomach | 99% | 344.25 | 357 / 359 | 98% | 45.62 | 281 / 286 |
| thymus | 100% | 405.97 | 651 / 653 | 98% | 18.10 | 592 / 605 |
| uterus | 99% | 273.25 | 169 / 170 | 98% | 21.05 | 450 / 459 |
| prostate | 100% | 345.16 | 244 / 245 | 98% | 18.43 | 490 / 502 |
| pancreas | 100% | 340.59 | 327 / 328 | 97% | 23.11 | 173 / 178 |
| lung | 97% | 489.14 | 561 / 578 | 99% | 34.25 | 1145 / 1155 |
| breast | 100% | 459.39 | 459 / 459 | 96% | 17.42 | 1068 / 1118 |
| skin | 99% | 486.48 | 1797 / 1809 | 88% | 15.62 | 417 / 472 |
| adrenal gland | 100% | 1569.78 | 258 / 258 | 77% | 11.93 | 177 / 230 |
| brain | 87% | 261.33 | 2311 / 2642 | 73% | 9.05 | 512 / 705 |
| adipose | 100% | 463.42 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 14.24 | 1 / 1 |
| muscle | 100% | 425.35 | 800 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 343.51 | 240 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 310.86 | 1324 / 1335 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 96% | 16.28 | 43 / 45 |
| heart | 94% | 474.54 | 812 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 86% | 10.19 | 25 / 29 |
| eye | 0% | 0 | 0 / 0 | 70% | 13.72 | 56 / 80 |
| peripheral blood | 41% | 217.19 | 382 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0005759 | Cellular component | mitochondrial matrix |
| GO_0004521 | Molecular function | RNA endonuclease activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0003727 | Molecular function | single-stranded RNA binding |
| GO_0008270 | Molecular function | zinc ion binding |
| Gene name | LACTB2 |
| Protein name | Endoribonuclease LACTB2 (EC 3.1.27.-) (Beta-lactamase-like protein 2) |
| Synonyms | CGI-83 |
| Description | FUNCTION: Endoribonuclease; cleaves preferentially 3' to purine-pyrimidine dinucleotide motifs in single-stranded RNA. The cleavage product contains a free 3' -OH group. Has no activity with double-stranded RNA or DNA. Required for normal mitochondrial function and cell viability. . |
| Accessions | Q53H82 ENST00000276590.5 ENST00000522447.5 |